Increased expression of PD-L1 is observed in inflammatory breast cancers (IBC), ER-negative breast cancer, PR-negative breast cancer, basal tumors, and triple-negative breast cancer (12, 13). The gene discussed is CD274; the disease is triple-negative breast carcinoma.